Shanghai Junshi Biosciences Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Junshi Biosciences has a total shareholder equity of CN¥6.6B and total debt of CN¥2.5B, which brings its debt-to-equity ratio to 38.5%. Its total assets and total liabilities are CN¥11.0B and CN¥4.4B respectively.
Key information
38.5%
Debt to equity ratio
CN¥2.54b
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥3.31b |
| Equity | CN¥6.60b |
| Total liabilities | CN¥4.38b |
| Total assets | CN¥10.99b |
Recent financial health updates
Shanghai Junshi Biosciences (HKG:1877) Has Debt But No Earnings; Should You Worry?
Jun 28
Is Shanghai Junshi Biosciences (HKG:1877) Using Debt Sensibly?
Mar 22Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?
Dec 17Health Check: How Prudently Does Shanghai Junshi Biosciences (HKG:1877) Use Debt?
Sep 05Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?
Oct 12Recent updates
Shanghai Junshi Biosciences Co., Ltd.'s (HKG:1877) Revenues Are Not Doing Enough For Some Investors
Aug 29Shanghai Junshi Biosciences (HKG:1877) Has Debt But No Earnings; Should You Worry?
Jun 28Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Fly 27% But Investors Aren't Buying For Growth
May 06Is Shanghai Junshi Biosciences (HKG:1877) Using Debt Sensibly?
Mar 22Risks Still Elevated At These Prices As Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Dive 29%
Jan 26Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?
Dec 17Is Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Trading At A 38% Discount?
Nov 20Health Check: How Prudently Does Shanghai Junshi Biosciences (HKG:1877) Use Debt?
Sep 05Revenues Not Telling The Story For Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
May 22Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Shares Could Be 35% Below Their Intrinsic Value Estimate
May 01A Look At The Intrinsic Value Of Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)
Jan 16Some Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 03Is Shanghai Junshi Biosciences (HKG:1877) A Risky Investment?
Oct 12Financial Position Analysis
Short Term Liabilities: 1877's short term assets (CN¥4.8B) exceed its short term liabilities (CN¥2.3B).
Long Term Liabilities: 1877's short term assets (CN¥4.8B) exceed its long term liabilities (CN¥2.1B).
Debt to Equity History and Analysis
Debt Level: 1877 has more cash than its total debt.
Reducing Debt: 1877's debt to equity ratio has increased from 22.7% to 38.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 1877 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 1877 has sufficient cash runway for 2.3 years if free cash flow continues to reduce at historical rates of 14.5% each year.